Nanolek Is A Russian Biopharmaceutical Company Founded In 2011 By Vladimir Khristenko And Mikhail Nekrasovin Collaboration With Rusnano And Epidbiomedthe Company Specializes In Producing Innovative And Import Substituting Drugswith A Strong Focus On Pediatric Vaccinesnanolek Operates High Tech Production Facilities That Meet Gmp And Iso Standardspositioning Itself As A Leader In The Russian Pharmaceutical Market The Company Offers A Diverse Range Of Biotechnological Products And Vaccines Aimed At Treating Socially Significant Diseasesincluding Cardiologyhivand Cancernotable Products Include Cibora Small Molecule Heparinand Brukinsadeveloped In Partnership With Beigenenanolek Has 20 Medicines In Its Portfolio And Plans To Release 35 More In The Coming Years Nanolek Collaborates With Major International Pharmaceutical Companies Like Sanofijanssenmerckand Aspenproducing Drugs At Its Gmp Certified Plantlooking Aheadnanolek Aims To Expand Its Production Capabilities And Develop New Vaccines For Various Diseasescontributing To Public Health Initiatives
No conferences found for this company.
| Company Name | Nanolek Llc |
| Country |
Russia
|
| Address | N/A |
| Telephone | N/A |
| N/A |
